In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Succinic acid, sulfo-, 1,4-bis(2-ethylhexyl) ester, sodium salt Drug Master File in Korea (Succinic acid, sulfo-, 1,4-bis(2-ethylhexyl) ester, sodium salt KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Succinic acid, sulfo-, 1,4-bis(2-ethylhexyl) ester, sodium salt. The MFDS reviews the Succinic acid, sulfo-, 1,4-bis(2-ethylhexyl) ester, sodium salt KDMF as part of the drug registration process and uses the information provided in the Succinic acid, sulfo-, 1,4-bis(2-ethylhexyl) ester, sodium salt KDMF to evaluate the safety and efficacy of the drug.
After submitting a Succinic acid, sulfo-, 1,4-bis(2-ethylhexyl) ester, sodium salt KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Succinic acid, sulfo-, 1,4-bis(2-ethylhexyl) ester, sodium salt API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Succinic acid, sulfo-, 1,4-bis(2-ethylhexyl) ester, sodium salt suppliers with KDMF on PharmaCompass.